14.01.2013 Views

Visit our Expo - Redox and Inflammation signaling 2012

Visit our Expo - Redox and Inflammation signaling 2012

Visit our Expo - Redox and Inflammation signaling 2012

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Session II : Receptor <strong>signaling</strong> <strong>and</strong> G proteins Poster II, 34<br />

SDF1 controls pituitary cell proliferation through the activation of ERK1/2 <strong>and</strong> the<br />

Ca2+-dependent cytosolic tyrosine kinase, Pyk2<br />

°Aless<strong>and</strong>ro Massa, *Silvia Casagr<strong>and</strong>e, °Adriana Bajetto, °Carola Porcile, °Federica<br />

Barbieri, °Stefano Thellung, °Sara Arena, °Aless<strong>and</strong>ra Pattarozzi, °Monica Gatti,<br />

°Aless<strong>and</strong>ro Corsaro, *Mauro Robello, °Gennaro Schettini, °Tullio Florio.<br />

°Section of Pharmacology, Dept. Oncology Biology <strong>and</strong> Genetics, University of Genova,<br />

Italy. *Unit INFM, Dept. of Physics, University of Genova, Italy .<br />

Stromal cell-Derived Factor 1 (SDF1) is a chemokine of the CXC subfamily involved in the<br />

recruitment of immune cells to sites of inflammation. SDF1 exerts its effects interacting with<br />

CXCR4, a G-protein coupled receptor. CXCR4 is often expressed by tumor cells <strong>and</strong> its<br />

activation causes tumor cell proliferation. To date, no evidence have been provided on the<br />

possible role of SDF1 in pituitary adenoma funcion, although it was reported the expression<br />

of CXCR4 in rat pituitary. In this work, we used GH4C1 cells as a model to study the effects<br />

of SDF1 in pituitary functions. In these cells, SDF1 induced dose-dependent proliferation.<br />

Thus we evaluated the intracellular <strong>signaling</strong> involved in this effect. SDF1 increased cytosolic<br />

[Ca2+] <strong>and</strong> activated Pyk2, ERK1/2 <strong>and</strong> BKCa channels. To correlate these intracellular<br />

effectors with the proliferative activity we inhibited their activity using BAPTA-AM (Ca2+<br />

chelator), PD98059 (MEK inhibitor), salicylate (Pyk2 inhibitor) <strong>and</strong> TEA (K+ channel<br />

blocker). All these compounds reverted SDF1-induced proliferation, suggesting the<br />

involvement of multiple intracellular pathways. To identify a possible cross-talk <strong>and</strong> a<br />

molecular ordering among this pathways, we tested these antagonists on SDF1 dependent<br />

activation of ERK1/2, Pyk2 <strong>and</strong> BKCa channels. We report that: the inhibition of [Ca2+]i<br />

increase or BKCa channels activity did not affect ERK1/2 activation by SDF1; Pyk2<br />

activation was purely Ca2+ dependent, not involving ERK1/2 or BKCa channels; BKCa<br />

channels activity was antagonized by Pyk2 but not by ERK1/2 inhibitors. These data suggest<br />

that SDF1- dependent increase of [Ca2+]i activates Pyk2, that, in turn, regulates BKCa<br />

channel activity. Conversely, ERK1/2 activation is an independent phenomenon. In<br />

conclusion we demonstrate that SDF1 causes proliferation of GH4C1 cells, suggesting that<br />

the activation of CXCR4 may represent a novel regulatory mechanism for pituitary cell<br />

proliferation, that may contribute to pituitary adenoma development.<br />

- 161 -

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!